References
- Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol 2007;25:2944–2951.
- Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 1985;9:543–569.
- Hoskin WF, Rubin SC. Malignant gonadal stromal tumors of ovary: clinical features and management. In: Coppleson M, editor. Gynecologic Oncology. Edinburgh: Churchill Livingstone; 1992:956–958.
- Appetecchia M, Cela V, Bernardi F, Burelli A, Cionini R, Pucci E. Sertoli-Leydig cell androgens-estrogens secreting tumor of the ovary: ultra-conservative surgery. Eur J Obstet Gynecol Reprod Biol 2004;116:113–116.
- Barbieri RL, Gao X. Presence of 17 beta-hydroxysteroid dehydrogenase type 3 messenger ribonucleic acid transcript in an ovarian Sertoli-Leydig cell tumor. Fertil Steril 1997;68:534–537.
- Tavassoli FA. Ovarian tumors with functioning manifestations. Endocrine Pathology 1994;5:137–148.
- Talerman A, Hughesdon PE, Anderson MC. Diffuse nonlobular ovarian androblastoma usually associated with feminization. Int J Gynecol Pathol 1982;1:155–171.
- Zung A, Shoham Z, Open M, Altman Y, Dgani R, Zadik Z. Sertoli cell tumor causing precocious puberty in a girl with Peutz-Jeghers syndrome. Gynecol Oncol 1998;70:421–424.
- Persechini ML, Motton S, Leguevaque P, Donadille F, Escourrou G, Vierasu B, Hamdi S, et al. Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour. Gynecol Endocrinol 2011;27:345–350.
- Rio Frio T, Bahubeshi A, Kanellopoulou C, Hamel N, Niedziela M, Sabbaghian N, Pouchet C, et al. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA 2011;305:68–77.
- White LC, Buchanan KD, O’Leary TD, Carlan SJ, Boothby R. Direct laparoscopic venous sampling to diagnose a small Sertoli-Leydig tumor. Gynecol Oncol 2003;91:254–257.
- Poli UR, Swarnalata G, Maturi R, Rao ST. Recurrent alpha-fetoprotein secreting Sertoli-Leydig cell tumor of ovary with an unusual presentation. Indian J Cancer 2009;46:64–66.
- Virk R, Lu D. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary. Pathol Res Pract 2010;206:489–492.
- Zhao C, Vinh TN, McManus K, Dabbs D, Barner R, Vang R. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol 2009;33:354–366.
- Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol 1976;125:402–411.
- Grove A, Vestergaard V. Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature. Ann Diagn Pathol 2006;10:288–293.
- Fox H. Endocrine pathology of ovarian neoplasia. In: Lowe D, Fox H, editors. Advances in gynecological pathology. Edinburgh: Churchill Living stone; 1992:266–267.
- Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol 1996;87:527–531.
- Farley JH, Taylor RR, Bosscher JR. Late presentation of an alpha-fetoprotein secreting isolated large upper abdominal retroperitoneal Sertoli-Leydig cell tumor recurrence. Gynecol Oncol 1995;56:319–322.